PharmaShots | Incisive News in 3 Shots

Subscribe Now

CHS-1420

Coherus Reports the US FDA's Acceptance of BLA for CHS-1420 (biosimilar- adalimumab)

Coherus Reports the US FDA's Acceptance of BLA for CHS-1420 (biosimilar- adalimumab)

February 18, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us